Share chart Biogen
Extended chart
Simple chart
About Biogen
Biogen Inc. — американская многонациональная биотехнологическая компания, базирующаяся в Кембридже, штат Массачусетс, специализирующаяся на открытии, разработке и поставке методов лечения нейродегенеративных, гематологических и аутоиммунных заболеваний пациентам во всем мире.| IPO date | 1991-09-16 |
|---|---|
| ISIN | US09062X1037 |
| Industry | Biotechnology |
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | usd |
| Див.доход ао | 0 |
| Дивиденд ао | 22.23 |
| Сайт | http://www.biogen.com |
| Цена ао | 139.16 |
| Change price per day: | -0.5606% (119.51) |
|---|---|
| Change price per week: | +0.1939% (118.61) |
| Change price per month: | -16.56% (142.43) |
| Change price per 3 month: | -18.71% (146.2) |
| Change price per half year: | -35.77% (185.01) |
| Change price per year: | -43.11% (208.9) |
| Change price per 3 year: | -40.48% (199.65) |
| Change price per 5 year: | -55.52% (267.15) |
| Change price per 10 year: | -51.48% (244.912) |
| Change price per year to date: | -22.29% (152.92) |
|
|
Underestimation
|
Efficiency
|
|||||||||||||||||||||||||||||||||||||
Dividends
|
Debt
|
Growth impulse
|
|||||||||||||||||||||||||||||||||||||
| Institutions | Volume | Share, % |
|---|---|---|
| PRIMECAP Management Company | 16264481 | 11.19 |
| Vanguard Group Inc | 14407330 | 9.91 |
| Blackrock Inc. | 14246658 | 9.8 |
| State Street Corporation | 6945665 | 4.78 |
| T. Rowe Price Investment Management, Inc. | 5357326 | 3.69 |
| Wellington Management Group, LLP | 5324396 | 3.66 |
| JP Morgan Chase & Company | 5011319 | 3.45 |
| Geode Capital Management, LLC | 3309317 | 2.28 |
| Invesco Ltd. | 1814666 | 1.25 |
| ClearBridge Investments, LLC | 1679302 | 1.16 |
| ETF | Share, % | Profitability for 1 year, % | Dividends, % |
|---|---|---|---|
| PSYK ETF | 4.07 | 0 | |
| Future Tech ETF | 2.81727 | 426.34 | 0.8416 |
| Principal Healthcare Innovators ETF | 2.81727 | 618.5 | 0.8416 |
| IQ U.S. Mid Cap R&D Leaders ETF | 2.48 | 0 | 0.82 |
| John Hancock Multifactor Healthcare ETF | 2.34 | 29.34 | 1.62 |
| iShares Evolved U.S. Innovative Healthcare ETF | 2.29 | 0.000586 | 2.79 |
| Invesco S&P 500® Equal Weight Health Care ETF | 1.77 | 815.08 | 0.64 |
| Nationwide Maximum Diversification U.S. Core Equity ETF | 1.52 | 26.65 | 1.58 |
| IQ Engender Equality ETF | 1.05205 | 30.64 | 1.74017 |
| Knowledge Leaders Developed World ETF | 0.91244 | 14.17 | 1.90235 |
| JPMorgan Corporate Bond Research Enhanced ETF | 0.32 | 6.26 | 4.16 |
| iShares Morningstar Mid-Cap ETF | 0.26833 | 260.95 | 1.7458 |
| Nationwide Nasdaq-100 Risk-Managed Income ETF | 0.19851 | 21.38 | 0.87606 |
| JPMorgan U.S. Aggregate Bond ETF | 0.18 | 5.54 | 1.33 |
| iShares Morningstar Large-Cap Value ETF | 0.11151 | 63.82 | 2.17567 |
| Columbia U.S. ESG Equity Income ETF | 0.10133 | -99.18 | 1.44131 |
| iShares Morningstar Large-Cap ETF | 0.05802 | 257.57 | 1.41244 |
| 1.37 | 145.71 | 1.52 |
| Head | Job title | Payment | Year of birth |
|---|---|---|---|
| Ms. Robin C. Kramer | Senior VP & Chief Accounting Officer | N/A | 1966 (59 years) |
| Ms. Natacha Gassenbach | Chief Communication Officer & Head of Corporate Affairs | N/A | |
| Ms. Nicole Murphy | Head of Pharmaceutical Operations & Technology | 1.46M | 1973 (52 years) |
| Mr. Michael R. McDonnell CPA | Executive VP & CFO | 2.12M | 1964 (61 year) |
| Ms. Susan H. Alexander Esq. | Executive VP & Chief Legal Officer | 2.2M | 1957 (68 years) |
| Mr. Christopher A. Viehbacher | President, CEO & Director | 487.94k | 1961 (64 years) |
| Mr. Charles E. Triano | Senior VP & Head of Investor Relations | N/A | |
| Mr. Adam Keeney Ph.D. | Executive VP & Head of Corporate Development | N/A | 1977 (48 years) |
| Mr. Rachid Izzar | Head of Global Product Strategy & Commercialization | 1975 (50 years) | |
| Dr. Ginger Gregory Ph.D. | Executive VP & Chief Human Resources Officer | 1968 (57 years) |
Address: United States, Cambridge, 225 Binney Street - open in Google maps, open in Yandex maps
Website: http://www.biogen.com
Website: http://www.biogen.com
